Malvern MedTech Cuts 20% of Staff as CFO Exits
MALVERN, PA — TELA Bio (Nasdaq: TELA) is cutting annual operating expenses by about $17 million and reducing its workforce by roughly 20%, a restructuring the medical technology company expects …
Malvern MedTech Cuts 20% of Staff as CFO Exits Read More